Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.42 CAD | -2.81% | +2.11% | +476.19% |
May. 22 | Medicenna to Present Clinical Update on MDNA11 ABILITY-1 Trial at Sachs Oncology Innovation Forum | MT |
May. 13 | Medicenna Says ABILITY-1 Abstract Withdrawn by ASCO Program Committee | MT |
- Stock Market
- Equities
- MDNA Stock
- News Medicenna Therapeutics Corp.
- MarketScreener Editorial Features